- Tytuł:
- Phase 1/2 study of CPX‐351 for patients with Int‐2 or high risk International Prognostic Scoring System myelodysplastic syndromes and chronic myelomonocytic leukaemia after failure to hypomethylating agents.
- Autorzy:
- Źródło:
- British Journal of Haematology. Mar2024, Vol. 204 Issue 3, p898-909. 12p.
Czasopismo naukowe